{"id":1292,"date":"2026-08-26T10:16:30","date_gmt":"2026-08-26T13:16:30","guid":{"rendered":"https:\/\/tirzeclub.com.br\/?p=1292"},"modified":"2026-08-26T15:53:44","modified_gmt":"2026-08-26T18:53:44","slug":"tirzepatida-gordura-visceral","status":"publish","type":"post","link":"https:\/\/tirzeclub.com.br\/en\/tirzepatida-gordura-visceral\/","title":{"rendered":"Tirzepatida, and visceral fat: why is the reduction of the waist-care for health"},"content":{"rendered":"

When someone makes you lose weight, the scale shows only part of the story. The two people lose about the same amount of weight, and the display changes to a different distribution of fat in the body. It is at this point that a visceral fat<\/strong> is more important.<\/p>\n\n\n\n

This type of fat is located deep in the abdomen, around the organs such as the liver, pancreas, and intestines. The excess is associated with insulin resistance, type 2 diabetes, changes in serum triglycerides and increased risk of cardiometab\u00f3lico.<\/p>\n\n\n\n

Studies Tirzepatida showing that weight loss may involve a significant reduction in the visceral fat<\/strong>. In a sub-body of the SURMOUNT-1, the participants, and are treated with Tirzepatida showed an average reduction of 40.1%, respectively, in the mass of adipose tissue in the visceral<\/strong> after 72 weeks, while the placebo group showed a reduction of 7.3%.<\/p>\n\n\n\n

These numbers help to explain why it is that the monitor only with the weight may not be enough. Waist circumference, body composition, and markers, metabolic, can be supplemented with relevant information about the changes that are taking place in your body.<\/p>\n\n\n\n

\n

- Important:<\/strong> this content is purely informative and does not replace medical evaluation, diagnosis and treatment have been added.<\/p>\n<\/blockquote>\n\n\n\n

What is visceral fat?<\/h2>\n\n\n\n

The fat does not get stored in one place.<\/p>\n\n\n\n

Part of it is located just beneath the skin. This tissue is called the subcutaneous fat, and this is the one that we were able to see with ease when you touch particular parts of the body.<\/p>\n\n\n\n

Already have the visceral fat<\/strong> it lies deeper in the abdomen, involving the internal organs.<\/p>\n\n\n\n

Have some of this fabric, it's normal. The problem is the excessive accumulation.<\/p>\n\n\n\n

When there is an excess of fat in abdominal depth, it is the most common metabolic disorders such as insulin resistance, high blood pressure, increased triglycerides, and an accumulation of fat in the liver. Population-based studies of recent as well as reinforce the association between the increased amount of adipose tissue and visceral changes, such as metabolic syndrome, type 2 diabetes and insulin resistance.<\/p>\n\n\n\n

For this reason, the distribution of fat doesn't matter as much as the total weight.<\/p>\n\n\n\n

Fat and abdominal visceral fat are they the same thing?<\/h2>\n\n\n\n

Not really.<\/p>\n\n\n\n

When we talk about \u201cstomach,\u201d we're looking at a combination of different weaves.<\/p>\n\n\n\n

In the abdominal area may include the following:<\/p>\n\n\n\n

    \n
  • the subcutaneous adipose tissue;<\/li>\n\n\n\n
  • adipose tissue, visceral;<\/li>\n\n\n\n
  • muscles;<\/li>\n\n\n\n
  • body<\/li>\n\n\n\n
  • liquid;<\/li>\n\n\n\n
  • the contents of the bowel.<\/li>\n<\/ul>\n\n\n\n

    For this reason, it is not possible to look into the lower abdomen of a person, and how much tissue, visceral, and she owns it.<\/p>\n\n\n\n

    In the same way, a reduction of the visual in the stomach does not allow you to calculate precisely how much of that material has been lost.<\/p>\n\n\n\n

    Imaging studies, and the methods of body composition can provide you with more detailed information in specific situations.<\/p>\n\n\n\n

    This type of fat worry about the most?<\/h2>\n\n\n\n

    Adipose (fat) tissue does not function only as a deposit liability of the energy.<\/p>\n\n\n\n

    It takes part in the production of hormones and the molecules involved in the body's metabolism.<\/p>\n\n\n\n

    When the accumulation of visceral, it's a high, there is an association with the changes, which promote insulin resistance, type 2 diabetes, and cardiovascular disease.<\/p>\n\n\n\n

    In a new study published in the 2024 in people with type 2 diabetes, also, it was observed that the treatment with Tirzepatida has been accompanied by a significant decrease in the adipose tissue and visceral fat in the liver.<\/p>\n\n\n\n

    This makes them the visceral fat<\/strong> especially relevant to the content on the obesity, and the health of metabolism: lose centimeters of the waist, it can represent the changes that go far beyond the look and feel.<\/p>\n\n\n\n

    The studies Tirzepatida find?<\/h2>\n\n\n\n

    An analysis of the composition of the body of the SURMOUNT-1 is rated to 160 participants, who carried out tests of a DXA scan at the beginning and after 72 weeks.<\/p>\n\n\n\n

    Among the participants, and are treated with Tirzepatida, the average reduction was from:<\/p>\n\n\n\n

      \n
    • 21.3% of the weight of the body<\/strong>;<\/li>\n\n\n\n
    • 33.9 percent of the mass of total fat<\/strong>;<\/li>\n\n\n\n
    • Up 10.9% of the lean body mass<\/strong>;<\/li>\n\n\n\n
    • 18,1 cm in waist circumference<\/strong>;<\/li>\n\n\n\n
    • 40.1%, respectively, of the mass of visceral fat<\/strong>.<\/li>\n<\/ul>\n\n\n\n

      In the placebo group, the average reduction in the visceral fat<\/strong> it was 7.3%.<\/p>\n\n\n\n

      These results show that the weight loss observed in this study was accompanied by significant decrease of abdominal fatness in-depth.<\/p>\n\n\n\n

      It is important to remember that this is a sub-160 participants within a much larger trial. Therefore, the numbers represent the average of the group, and not a prediction of what will happen to each and every person.<\/p>\n\n\n\n

      Lose 40% of the visceral fat means losing 40% of your stomach?<\/h2>\n\n\n\n

      No.<\/p>\n\n\n\n

      Such an interpretation would be incorrect.<\/p>\n\n\n\n

      The value of 40.1%, respectively, found in this study refers to the mass of the adipose tissue in the visceral estimated by DXA.<\/p>\n\n\n\n

      The waist circumference decreased by an average of 18.1 inches in the same group, but are different lengths.<\/p>\n\n\n\n

      The tummy is visible, it also contains the fat under the skin, muscles, and other tissues.<\/p>\n\n\n\n

      A person may notice a great change in the clothing or in the tape without having to know exactly what percentage of the tissue, visceral has been deleted.<\/p>\n\n\n\n

      \"Pessoa<\/figure>\n\n\n\n

      Through the dropped waistline to study?<\/h2>\n\n\n\n

      The reduction of the waist, likely to reflect a combination of fat loss, the total reduction of the abdominal tissue, and the changes in the composition of the body.<\/p>\n\n\n\n

      In the study of the composition of the body of the SURMOUNT a-1, a reduction in the average 18,1 cm<\/strong> it was much larger than that of the 3,4 cm<\/strong> seen in placebo recipients.<\/p>\n\n\n\n

      This is interesting because of it's simple to do and can be repeated from time to time.<\/p>\n\n\n\n

      It does not replace scans, but it can show changes in the scale did not show on her own.<\/p>\n\n\n\n

      For example, you can spend a couple of weeks, with very little variation in weight, and also to reduce inches from your waist.<\/p>\n\n\n\n

      The tape measure can measure the visceral fat?<\/h2>\n\n\n\n

      Not directly.<\/p>\n\n\n\n

      The tape-measure your waist circumference.<\/p>\n\n\n\n

      This measure correlates with adiposity, central, and it can help in the assessment of the risk of cardiometab\u00f3lico, but it does not mean that it is the tissue beneath the skin that is around your body.<\/p>\n\n\n\n

      To quantify the visceral fat<\/strong> in particular, the methods, such as ct scan, magnetic resonance imaging, or specific equipment from the DXA scan can be used.<\/p>\n\n\n\n

      In practice, however, not all patients have these tests done.<\/p>\n\n\n\n

      Weight, BMI, waist-to, laboratory tests, blood pressure, and medical history will often provide sufficient information for follow-up.<\/p>\n\n\n\n

      Where to measure waist?<\/h2>\n\n\n\n

      The technique used should be consistent.<\/p>\n\n\n\n

      There are many different protocols, and the exact location can vary depending on the guideline, or the purpose of the assessment.<\/p>\n\n\n\n

      The most important thing for those who follow developments in the house is trying to loop forever:<\/p>\n\n\n\n

        \n
      • to the same point in the lower abdomen;<\/li>\n\n\n\n
      • at the same location;<\/li>\n\n\n\n
      • a strip with no overtighten the skin;<\/li>\n\n\n\n
      • similar conditions;<\/li>\n\n\n\n
      • preferably, in the same time.<\/li>\n<\/ul>\n\n\n\n

        To change the measurement point in each week, it can produce differences that do not correspond to the actual change.<\/p>\n\n\n\n

        The waist can be cut without the balance in the download?<\/h2>\n\n\n\n

        Yes.<\/p>\n\n\n\n

        Body weight varies depending on several factors, including the water, glycogen stores, the contents of the bowel, and other physiological fluctuations.<\/p>\n\n\n\n

        For this reason, short-term changes in the balances are not always represent the net gain or loss of body fat.<\/p>\n\n\n\n

        The gradual reduction of the waist, can be a helpful sign of the change in the body, especially when assessed with the trend of your weight and other indicators.<\/p>\n\n\n\n

        This does not mean that each and every inch of the lost is a certain amount of visceral fat<\/strong>.<\/p>\n\n\n\n

        The follow-up works best, the use of different measures are to be taken together.<\/p>\n\n\n\n

        Individuals with the same BMI may have different risks?<\/h2>\n\n\n\n

        Yes.<\/p>\n\n\n\n

        The BMI is useful for population-based studies, and for clinical evaluation, but it does not show where the fat is distributed.<\/p>\n\n\n\n

        Two people of the same weight and height, you can display a different amount of the fabric that is visceral, muscle mass, or fat under the skin.<\/p>\n\n\n\n

        It is for this reason that, in the assessment of obesity should not be limited solely to the number that is listed by BMI.<\/p>\n\n\n\n

        The waist circumference and the presence of other changes, such as high blood pressure, pre-diabetes, diabetes, type 2 diabetes, dyslipidemia, and hepatic steatosis help you to build up a more complete picture of the risk is age.<\/p>\n\n\n\n

        Tirzepatida \u201cthe burning\u201d - specifically belly fat?<\/h2>\n\n\n\n

        It is not proper to display in the medicine in this way.<\/p>\n\n\n\n

        The Tirzepatida does not function as a localized treatment to the abdomen.<\/p>\n\n\n\n

        It works on mechanisms related to the receptors for GIP and GLP-1, that regulates your appetite, reduces food intake and produces a feeling of satiety. The indication is transferred to the control of chronic weight is attached to a low-calorie diet and increased physical activity for adults who meet the criteria established by the brazilian health surveillance agency.<\/p>\n\n\n\n

        With the weight loss, is the reduction of body fat in different areas.<\/p>\n\n\n\n

        Studies show a reduction in major visceral fat<\/strong>but that doesn't mean that it's the medicine, the choice is exclusively in the stomach as a site of loss.<\/p>\n\n\n\n

        The drug eliminates only fat?<\/h2>\n\n\n\n

        No.<\/p>\n\n\n\n

        This is an important point.<\/p>\n\n\n\n

        In the sub-to the SURMOUNT-1, is approximately 74% of body weight is lost<\/strong> in the group of Tirzepatida corresponds to the mass of the fat, and some of the 26% of the lean body mass<\/strong>.<\/p>\n\n\n\n

        \u201cLean body mass\u201d to mean not only the muscle. This includes water, organs, tissues, and other components are free of grease.<\/p>\n\n\n\n

        Nevertheless, these data emphasize the importance of maintaining muscle mass during weight loss with proper diet and exercise is strength.<\/p>\n\n\n\n

        For this reason, a reduction in the visceral fat<\/strong> it must take place within a broader goal of improving body composition and health, and it's not just the lower the number on the scale.<\/p>\n\n\n\n

        Read more:<\/strong> Tirzepatida, and body composition: how much of the loss in weight is fat and how much is lean body mass?<\/p>\n\n\n\n

        Exercise helps to reduce abdominal fatness?<\/h2>\n\n\n\n

        Physical activity is an important part of the treatment of obesity.<\/p>\n\n\n\n

        Aerobic exercise can contribute to energy expenditure, cardiovascular fitness, and insulin sensitivity.<\/p>\n\n\n\n

        Strength training helps maintain or develop your muscles and the ability to function.<\/p>\n\n\n\n

        A routine combo can be especially helpful for weight loss.<\/p>\n\n\n\n

        In addition, the exercise should not be seen merely as a tool to \u201cburn calories\u201d. It can improve health, when the balance changes the little one.<\/p>\n\n\n\n

        Your own statement is approved by the Fda established the Tirzepatida for weight management as an adjunct to diet with a calorie reduction and increased physical activity.<\/p>\n\n\n\n

        Power does it make a difference?<\/h2>\n\n\n\n

        Yes.<\/p>\n\n\n\n

        The Tirzepatida you can reduce the appetite and ease a shortage of energy, but that does not make the quality of the food to be irrelevant.<\/p>\n\n\n\n

        During weight loss, it is important to consume adequate amounts of protein, dietary fiber, vegetables, and other ingredients.<\/p>\n\n\n\n

        Lower excess on a regular maintenance ultraprocessados, and sugary drinks can also facilitate the control of energy metabolism.<\/p>\n\n\n\n

        A diet too restrictive, can make it difficult for the intake of nutrients and the maintenance of lean body mass.<\/p>\n\n\n\n

        The goal should be to create a sustainable and not just to eat as little as possible.<\/p>\n\n\n\n

        The reduction of the waist, improve insulin resistance?<\/h2>\n\n\n\n

        There is an important relationship between the abdominal fatness, and insulin resistance.<\/p>\n\n\n\n

        When there is a loss of weight, and a decrease in the visceral fat<\/strong>it is not uncommon to see an improvement of insulin sensitivity and other markers in the metabolic.<\/p>\n\n\n\n

        This does not mean that the whole of the reduction of the waist, will produce the same change in the blood sugar (glucose).<\/p>\n\n\n\n

        Genetics, pancreatic function, nutrition, physical activity, medications, and duration of the metabolic changes have also had an influence.<\/p>\n\n\n\n

        In the case of the Tirzepatida, the Fda reports that the drug also increases your sensitivity to insulin, in addition to its effects on appetite and food intake.<\/p>\n\n\n\n

        Read more:<\/strong> Tirzepatida, and insulin resistance: how the drug acts on the metabolism of glucose.<\/p>\n\n\n\n

        And the fat on the liver?<\/h2>\n\n\n\n

        Fat and visceral fat in the liver, often appearing together in the context of insulin resistance and obesity, the metabolic.<\/p>\n\n\n\n

        Studies Tirzepatida in people with type 2 diabetes, and found reductions in both the tissue, the visceral and the fat of the liver.<\/p>\n\n\n\n

        This helps to explain why the evaluation of the metabolic not take account of your organs and tissues in a completely isolated from each other.<\/p>\n\n\n\n

        The improvement in weight, it can occur at the same time as changes in the liver and in the blood and in fat distribution in the body.<\/p>\n\n\n\n

        Read more:<\/strong> Tirzepatida, and the fat of the liver: what the studies show.<\/p>\n\n\n\n

        You need to make a DXA scan to keep track of?<\/h2>\n\n\n\n

        In the majority of cases, it's not.<\/p>\n\n\n\n

        The DXA scan is very helpful in the search, and it can be used clinically for some reviews, but there is no need to take it repeatedly just to see if the treatment is working.<\/p>\n\n\n\n

        Indicators are simple to do and can be accompanied along the way.<\/p>\n\n\n\n